/Investor DB

AIS CAPITAL

Venture capital

Tokyo · Series A · 9 people tracked

Also known as AIS CAPITAL MANAGEMENT L.P.

Find your way into AIS CAPITAL

Sign up to see every warm intro you have to AIS CAPITAL

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the AIS CAPITAL team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

AIS CAPITAL focuses on cross-border investment and advisory between Japan and the Greater China region, leveraging a team with venture investment and investment banking backgrounds familiar with both Chinese and Japanese markets. It offers professional advisory services covering M&A, strategic and financial investment, JV establishment, and business alliances between Japanese and Chinese companies. The firm also runs a cross-border incubation business, supplying growth capital to Japanese and Chinese ventures and supporting their expansion into each other's markets, including introductions to local partners. Activities span cross-border investment/lending advisory, proprietary and fund-based investment, and international real estate business.

Source: firm website, verified Oct 25, 2026.

Stage
Series A
HQ
Tokyo, JP
Instruments
Equity · Debt
Founded
2017
AUM
$358.3M
Tracked investments
4

Team · 9 people

from the firm's website & public directories
崔 浩· 代表パートナー
崔皓· 代表パートナー / マネージング・ディレクター (Representative Partner / Managing Director)

Holds two master's degrees from the University of Tokyo (technology management strategy and precision engineering). Worked in Daiwa Securities Group's principal investment division in Tokyo and Singapore, then handled PE investments in consumer goods, theme parks, and real estate at Fosun Group's Japan arm. Fluent in Japanese, English, and Chinese. Joined AIS Capital as Managing Director in 2020.

肖敏捷· 代表パートナー

Wuhan University graduate and University of Tsukuba doctoral program completer. A longtime economist specializing in the Chinese economy and financial markets at Daiwa Institute of Research and SMBC Nikko Securities. Author of books on the Chinese economy and a TV commentator. Joined AIS Capital as representative partner in 2018.

郭健· 代表パートナー

Waseda University Law graduate and part-time researcher at Kyoto University. Has worked in business investment (M&A) and venture investment at a trading house, a securities-affiliated PE firm, and a major Chinese operating company group, specializing in Japan-China synergy-focused investing. Previously at Marubeni (2006), Daiwa SMBC Capital China fund as Managing Director (2009), and Fujian Sunner Group (2015) before founding AIS Capital in 2017.

土屋立暢· パートナー (Partner)

Waseda University graduate. Worked in financial due diligence, valuation, and advisory for M&A and corporate restructuring at PwC and Deloitte Japan (2000-2014), then served as financial investigation head and fund manager at the government-affiliated fund REVIC (2015-2018), overseeing investments across agriculture, food processing, SaaS, hospitality, and real estate.

安藤英広· 顧問 (Advisor)

University of Tokyo agriculture graduate with roughly 35 years in pharmaceutical business development and licensing, including roles at Tanabe (now Mitsubishi Tanabe Pharma), RIKEN, Bayer, and biotech ventures. Now supports licensing and joint research deals for domestic and foreign pharmaceutical companies and startups.

武田勝年· 特別顧問 (Special Advisor)

Former Managing Executive Officer and China Chief Representative of Mitsubishi Corporation. University of Tokyo economics graduate who led Mitsubishi's China business for many years, serving as head of its Shanghai and Beijing offices. Joined AIS Capital as special advisor in 2019.

Bradley C. Stern· Executive Officer
John R. Hummel· Executive Officerin

What they invest in

from 1 of 4 portfolio companies

Biotech ×1Consumer ×1Healthtech ×1Longevity ×1Wellness & Fitness ×1

HQs:Japan×1

Investments · 4 tracked

founders shown can be your intro path
AutoPhagyGOautophagygo.com

AutoPhagyGO is a biotech company focused on autophagy research with applications in longevity and age-related disease prevention and treatment.

BiotechConsumerHealthtechLongevityWellness & FitnessTokushima, JP

Yasushi Yoshimori(Founder)Ishido(CEO)石堂 美和子 (Miwako Ishido)(Representative Director & CEO)in

Board吉森 保 (Tamotsu Yoshimori)(Technical Advisor)

Co-investorsUntroD Capital

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

RoboTrackロボトラックロボトラック (RoboTruck)

Frequently asked questions

What stage does AIS CAPITAL invest at?
AIS CAPITAL invests at the Series A stage.
What sectors does AIS CAPITAL focus on?
AIS CAPITAL focuses on AI & Machine Learning, Biotech, Retail Tech, Robotics, Sector Agnostic.
Where is AIS CAPITAL located?
AIS CAPITAL is headquartered in Tokyo, JP.
Who does AIS CAPITAL co-invest with?
AIS CAPITAL most often shares deals with JIC Venture Growth Investments, ON&BOARD, UntroD Capital, among 4 tracked co-investors.

Similar investors

Featured in lists